Background-In congestive heart failure (CHF), the prognostic significance of impaired respiratory muscle strength has not been established. 
I
n congestive heart failure (CHF), accurate assessment of disease severity and risk stratification are crucial for the optimal selection of candidates and the timing of cardiac transplantation. Currently, judgment of prognosis is primarily based on hemodynamic parameters and the impairment of functional capacity. In particular, peak oxygen consumption during cardiopulmonary exercise testing (peak V O 2 ) has been widely recommended for risk stratification. 1, 2 However, the existence of an optimal peak V O 2 cut-off value for the prediction of survival in CHF remains a matter of debate. 2 The continuous parameter peak V O 2 is determined by cardiac output and by pulmonary and skeletal muscle function. 3 In severe CHF, a general atrophic loss of skeletal muscle bulk in patients has been reported. 4 Moreover, even in early stages of CHF, peripheral muscle function is impaired due to structural and metabolic abnormalities of skeletal musculature. 5 Biopsies of respiratory muscles showed a variety of histological abnormalities in CHF, 6 including fiber type I atrophy of the diaphragm in experimental CHF in rats. 7 Both a generalized skeletal muscle dysfunction and a chronically increased workload may result in decreased strength and endurance of respiratory muscles in CHF. 8 -16 Thus far, respiratory muscle strength has not been evaluated as an indicator of prognosis in various degrees of CHF. Earlier data from our laboratory indicated that respiratory muscle strength might be reduced in CHF patients who have an unfavorable outcome. 8 Thus, it was hypothesized that respiratory muscle function might be a predictor of survival in patients with CHF. Therefore, maximal inspiratory pressure (Pi max ) was prospectively assessed in CHF patients with a wide range of exercise limitations, and the impact of Pi max for prognosis was determined during long-term follow-up. This study sought to clarify whether Pi max predicts survival independently of established predictors of prognosis (left ventricular ejection fraction [LVEF], peak V O 2, , and norepinephrine) and whether the combination of Pi max with other noninvasive prognostic parameters improves risk stratification in patients with CHF.
Methods
A total of 244 consecutive patients (207 men, 85%) with stable CHF (NYHA functional class I, nϭ31 [13%]; class II, nϭ100 [41%]; class III, nϭ113 [46%]) were prospectively enrolled after they gave written, informed consent. The study was approved by the Ethical Committee for human research of the University of Heidelberg.
The cardiac diagnosis was based on left heart catheterization and coronary angiograms taken before study inclusion. LVEF at rest was Ͻ40%, as determined by radionuclide ventriculography. 17 Standard medical treatment was optimized for the individual patient before inclusion into the study and included angiotensin-converting enzyme inhibitors (97% of patients), diuretics (87%), digitalis (72%), and ␤-blockers (34%). Patients were studied while on stable doses of their medications. Blood samples were taken to exclude conditions that could possibly affect respiratory muscle function (eg, thyroid dysfunction, electrolyte disturbance) and to determine blood gases and plasma concentrations of norepinephrine, as described elsewhere. 17 Patients with valvular defects, a history of pulmonary disease, or an episode of deterioration requiring intravenous inotropic support within 4 weeks before enrollment were excluded. Patients meeting the recently described criteria for cachexia or wasting 4 or with symptoms at rest (NYHA functional class IV) were excluded, because particularly poor prognosis has been well established for these CHF subgroups.
Pulmonary and Respiratory Muscle Function Testing
A technician who was unaware of other variables in the study and who was blinded to the status of the patient determined inspiratory vital capacity (IVC) and forced expiratory volume in 1 s using a pneumotachograph (Erich Jaeger, MasterLabPro 4.2). Predicted values corrected for sex, age, and height were used. 18 Pi max was determined through a flanged mouthpiece in deep inspiration from functional residual capacity against a shutter with a minor air leak preventing undesirable glottis closure (Erich Jaeger, MasterLabPro 4.2). 19 Maximal expiratory pressure (Pe max ) was measured at total lung capacity during a maximal expiratory effort. Of 3 measurements with Ͻ5% variability, the highest pressure was used for analysis. Two minutes of rest were allowed between the 2 maneuvers when necessary. Mouth occlusion pressure (P 0.1 ) was assessed 0.1 s after the onset of inspiration during spontaneous breathing at rest. 20 Pi max and P 0.1 are expressed as positive values, although they are negative pressures with respect to atmosphere. Because published reference values for Pi max , Pe max , and P 0.1 vary considerably, 19, 20 they were determined in 25 control subjects who were not on medication and who had normal left ventricular function, as determined by echocardiography (Table 1) .
Cardiopulmonary Exercise Testing
Patients underwent symptom-limited exercise testing in a semisupine position on a bicycle ergometer until exhaustion, according to a modified Bruce protocol. 8, 17 Briefly, after 5 minutes of sample collection at rest, exercise started with 2 minutes at 0 W. Workload was increased in steps of 15 W every 2 minutes. Airflow and expiratory O 2 concentrations were continuously analyzed and averaged online from 8 consecutive breaths (OxyconAlpha, Jaeger; face mask by Hans Rudolph, Wyandotte).
Follow-Up
Patients were included and followed from March 1996 until January 2000 at regular outpatient visits or by telephone calls to the patients' home or family physician.
The predefined end point was all-cause mortality. Aortocoronary bypass grafts and left ventricular assist devices were not inserted in the studied patients. Those patients who underwent orthotopic heart transplantation were followed until the surgical procedure. Regardless of the postoperative outcome, these patients were classified as survivors.
Statistics
Statistical analysis was performed with standard software (SAS version 6.09 and Microsoft Excel version 1997). The Spearman rank correlation coefficient was used as a measure of association. To test for differences between groups, a 2-sample-Wilcoxon-test was used.
Survival curves were calculated using the Kaplan-Meier method. Cox proportional hazard linear regression analysis was used to determine the prognostic value for a given independent continuous variable on time to death. Receiver-operating characteristic curves were constructed by means of plotting true-positive rates (sensitivity) against false-positive rates (1/specificity). PϽ0.05 was considered significant. Values are expressed as meanϮSD.
Results

Clinical Correlation
The duration of CHF before inclusion into the study was 59Ϯ62 months (range, 1 to 300 months). Compared with control subjects, Pi max was reduced by 23% in CHF, whereas Pe max (Table 1 ) and arterial carbon dioxide pressure (PaCO 2 ; 37Ϯ4 versus 38Ϯ3 mm Hg; PϭNS) did not differ. In CHF patients, IVC and forced expiratory volume in 1 s were correlated (rϭ0.9; Pϭ0.0001) and were significantly lower than in controls, indicating a mild restrictive pattern in CHF ( 
Survival Analysis
During follow-up (23Ϯ16 months; range, 1 to 46 months) 57 patients died (mean time to death, 16Ϯ12 months; range, 1 to 44 months), all from cardiovascular causes. The 1-, 2-, and 3-year mortality was 12%, 23%, and 30%, respectively. Thirty-eight patients underwent cardiac transplantation after 13Ϯ9 months (range, 1 to 37 months).
Nonsurvivors and survivors did not differ in age, height, weight, NYHA functional class, or PaCO 2 (37Ϯ4 versus 37Ϯ4 mm Hg; PϭNS). However, nonsurvivors were characterized by a reduced LVEF, a decreased exercise capacity (as reflected by a reduction in maximal workload and peak V O 2 ), and increased plasma concentrations of norepinephrine (Table 2). Furthermore, nonsurvivors had significantly smaller lung volumes than survivors, but no signs of airflow obstruction (Table 2) . Although P 0.1 , an index of respiratory center output, did not differ in survivors and nonsurvivors (Tables 1  and 2 ), Pi max was reduced by 22% in nonsurvivors compared with survivors (Table 2) .
Kaplan-Meier survival curves for patients subdivided in quartiles according to Pi max allowed accurate prognostic stratification (Figure 1) . A high Pi max (Ͼ9.8 kPa) indicated the best prognosis at 12, 24, and 36 months of follow-up compared with lower Pi max quartiles. Survival in this highest Pi max quartile group was 3-fold higher than in patients in the lowest Pi max quartile (Ͻ5.3 kPa; Figure 1 were analyzed separately, a low Pi max (Ͻ5.3 kPa) indicated a 20% and 40% reduction in survival rate at 12 and 36 months, respectively, compared with a high Pi max (Ͼ9.8 kPa; Figure 2 ). Sensitivity and specificity of Pi max for predicting survival at 12 and 36 months was assessed for different arbitrary thresholds (Table 3) . Of all nonsurvivors, 64% and 59% had a Pi max Յ7 kPa (sensitivity) at 12 and 36 months follow-up, respectively. In 58% and 60% of survivors, Pi max was Ͼ7 kPa (specificity) after 12 and 36 months, respectively. Lower thresholds provided a higher sensitivity but a lower specificity and vice versa.
Univariate and Multivariate Analysis
In the univariate Cox regression analysis, Pi max , LVEF, peak V O 2 ( (Figure 3 ). Addition of plasma norepinephrine did not further improve risk prediction.
Discussion
The major findings of this prospective study in 244 CHF patients are as follows. (1) 
Respiratory Muscle Dysfunction is Related to Severity of CHF
As shown previously, the reduction in respiratory muscle strength as determined by Pi max is related to the severity of CHF. 8,9,14 -16 This is confirmed by the decline in Pi max with increasing NYHA functional class and the correlation between Pi max and peak V O 2 in the present and previous reports. 8, 9, 21 In the CHF patients, Pi max was related to IVC. However, a restrictive ventilatory pattern does not seem to be responsible for changes in Pi max , because the decline of Pi max with increasing severity of CHF was still observed when Pi max was corrected for IVC (data not shown).
Increased respiratory muscle strain did not play a major role in the observed reduction in Pi max in CHF, because P 0.1 (an index of respiratory center output 20 ) was not augmented. This finding is consistent with previous observations. 8, 10 When P 0.1 was corrected for individual respiratory muscle strength (P 0.1 /Pi max ), again no difference between groups was found (data not shown).
Respiratory Muscle Strength and Survival
Because Pi max is a continuous parameter, values obtained in the present cohort were divided into 4 quartiles corresponding to 4 risk strata (Figure 1 ). For the lowest Pi max quartile of the cohort, mortality was increased 3-fold compared with patients who had CHF but preserved respiratory muscle strength (Pi max Ͼ9.8 kPa; Figure 1 ). Approximately 50% of patients with Pi max Յ5 kPa died during follow-up, but only 15% of those with Pi max Ͼ10 kPa died ( Figure 1 and Table 3 ). These data provide the first evidence that respiratory muscle strength may be a powerful indicator of prognosis in CHF. Because in CHF patients with an intermediate peak V O 2 of 10 to 20 mL · min -1 · kg -1 risk stratification solely based on peak V O 2 is often inaccurate, 22 the use of Pi max as an additional factor for risk stratification is particularly important. Of the 244 patients in this study, 160 belonged to that group. Those belonging to the highest Pi max quartile (nϭ37) had a 1-year survival rate of 100%, whereas 22% of those in the lowest quartile (nϭ45) died within the first year. Therefore, in the majority of the patients with an intermediate peak V O 2 , Pi max allowed significantly better risk stratification than peak V O 2 alone. Because peak V O 2 is dependent on patients' motivation to endure an incremental exercise test, it frequently underestimates exercise capacity in candidates for cardiac transplantation. 22 Moreover, peak V O 2 globally assesses cardiac, respiratory, and peripheral muscle function during exercise, 3 which may all contribute to exercise limitation. Therefore, selected parameters derived from exercise testing, such as ventilatory and heart rate response, have recently been suggested as better predictors of CHF mortality than peak V O 2 . 23 In a different approach to improve risk stratification in CHF, a heart failure survival score (HFSS) was recently proposed. The HFSS would combine multiple, independent, noninvasive variables. 24 Peak V O 2 alone predicted freedom of an outcome event (death, urgent transplantation, or implantation of ventricular assist device within 12 months) with an AUC of 0.62, whereas the HFSS noninvasive multivariate model provided an AUC of 0.76. 24 The patients analyzed by HFSS and the present cohort are comparable in size and baseline clinical parameters. In the present study, peak V O 2 alone predicted 1-year survival with an AUC of 0.73. When Pi max was added, AUC increased to 0.75. With the combination of the significant predictors identified by multivariate Cox regression analysis (Pi max , peak V O 2 , and LVEF), the AUC increased to 0.82 (Figure 3 ). These findings underline the fact that a multivariable model is preferable to risk stratification relying on a single parameter only. Moreover, the present data suggest including respiratory muscle function in comprehensive prognostic models as an independent predictor.
Clinical Implications and Further Investigation
The present findings are of major clinical importance because the measurement of Pi max is noninvasive and independent of the patients' ability to walk or cycle. The determination of Pi max is easily performed during routine pulmonary function testing. 19 Although Pi max depends on patients' cooperation, repeated measurements revealed good reproducibility after 3 days 19 and after 3 months. 25 Although Pi max values in the present control group are comparable to data published elsewhere, 19, 20 substantial variation in Pi max between different laboratories, depending on equipment and technique, may occur. Thus, risk stratification using the Pi max strata observed in the present study depends on reference values of individual laboratories.
The reduction in respiratory muscle strength may reflect increased work of breathing in CHF. 12 As shown previously, restrictive ventilatory pattern, ventilatory inefficiency, and increased dead space ventilation may occur in CHF and partially contribute to the overload of the respiratory musculature in CHF, although respiratory drive as assessed by P 0.1 and PaCO 2 at rest are not increased. 8 Alternatively, the reduction in Pi max may be due to a generalized skeletal muscle disorder in CHF. 4, 5, 9 However, the unchanged Pe max is a strong argument against this hypothesis.
It has been shown that the reduction in inspiratory muscle strength in CHF is associated with a significant decline in respiratory muscle endurance, as measured by various techniques. 21, 26, 27 Therefore, the assessment of respiratory muscle endurance, eg, by measuring maximal voluntary ventilation, might be another valuable parameter for risk stratification in CHF. As opposed to Pi max , however, maximal voluntary ventilation is influenced by reduced static lung volumes, thus reflecting respiratory muscle capacity less accurately than Pi max .
Respiratory muscle function can be improved by selective respiratory muscle training 25 or by unloading respiratory muscles with noninvasive continuous positive airway pressure ventilation during acute training and long-term disease in selected patients. 28, 29 In conclusion, CHF is characterized by respiratory muscle dysfunction. For the first time, respiratory muscle strength has been characterized as an independent predictor of prognosis in CHF. The easily obtainable Pi max might thus serve as a new parameter to further improve risk stratification in patients with CHF.
